Chapter title |
Strategies to Maintain Fertility in Young Breast Cancer Patients
|
---|---|
Chapter number | 1 |
Book title |
Optimizing Breast Cancer Management
|
Published in |
Cancer treatment and research, January 2018
|
DOI | 10.1007/978-3-319-70197-4_1 |
Pubmed ID | |
Book ISBNs |
978-3-31-970195-0, 978-3-31-970197-4
|
Authors |
Elizabeth S. Constance, Molly B. Moravek, Jacqueline S. Jeruss |
Abstract |
Breast cancer is the most frequently occurring cancer in women of reproductive age. Treatments for breast cancer may eliminate or diminish fertility, making discussions about fertility preservation essential prior to initiation of gonadotoxic therapies. Additionally, even in patients who do not require chemotherapy, the use of adjuvant endocrine therapy will often push patients out of the reproductive window before treatment is completed. The only established methods for fertility preservation are oocyte or embryo cryopreservation, but experimental methods, such as ovarian suppression with GnRH agonists and ovarian tissue cryopreservation, show great promise. Early referral to a fertility specialist for interested patients affords patients the most fertility preservation options, with only minimal delay to cancer treatment. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 20% |
Other | 2 | 13% |
Student > Bachelor | 2 | 13% |
Researcher | 2 | 13% |
Student > Doctoral Student | 1 | 7% |
Other | 1 | 7% |
Unknown | 4 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 8 | 53% |
Biochemistry, Genetics and Molecular Biology | 1 | 7% |
Sports and Recreations | 1 | 7% |
Engineering | 1 | 7% |
Unknown | 4 | 27% |